Company intelligence / Profile preview
Changxing Pharmaceutical
Huzhou / Changxing, Zhejiang, China
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
Changxing Pharmaceutical is primarily a generic and API manufacturer that has participated in bioequivalence and clinical trials, including flupirtine maleate for pain and proprietary polysaccharide capsules for chronic renal failure. Its clinical programs focus on bioequivalence and traditional Chinese medicine products, with some fully approved and marketed generics.[7]
- Therapeutic areas
- NeurologyNephrologyOther
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Changxing Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changxing Pharmaceutical.